Table 1.

Patients demographic and baseline characteristics in patients with available baseline hsCRP and IL-6a

Baseline VariablesbPatients with hsCRP Data (n = 1910)Patients with IL-6 Data (n = 1751)
Cholesterol (mmol/L)6.48 (1.13)6.52 (1.13)
HDL cholesterol (mmol/L)1.34 (0.45)1.34 (0.45)
LDL cholesterol (mmol/L)4.18 (1.02)4.19 (1.01)
Apolipoprotein B (mg/dl)117.97 (25.88)117.08 (25.63)
Triglycerides (mmol/L)2.22 (1.39)2.21 (1.39)
Age at baseline (yr)49.7 (10.0)49.5 (11.0)
Total time on RRT (mo)89.0 (57.9)89.2 (57.8)
Systolic BP (mmHg)144.0 (19.0)145.0 (19.0)
Diastolic BP (mmHg)86.0 (10.0)86.0 (10.0)
Diabetes mellitus361 (19.0)327 (18.7)
Body mass index (kg/m2)25.7 (4.3)25.6 (4.18)
Serum creatinine (μmol/L)145.0 (53.0)145.0 (53.0)
Serum glucose (mg/dl)93.4 (51.5)93.0 (51.0)
PTH (pg/ml)51.65 (66.6)50.72 (65.07)
hsCRP (mg/L)3.82 (6.71)
IL-6 pg/ml2.92 (1.87)
Coronary heart disease N (%)175 (9.2)145 (8.3)
Diabetes mellitus N (%)361 (19)327 (18.7)
Smoking (current) N (%)358 (18.8)326 (18.6)
Living donor transplant N (%)427 (22.4)400 (22.8)
Cadaveric donor transplant N (%)1477 (77.5)1351 (77.2)
MACE N (%)287 (15.1)256 (14.6)
All-cause death N (%)354 (18.6)309 (17.6)
  • a Data are expressed as mean (SD) unless otherwise indicated.

  • b hsCRP, high-sensitivity C-reactive protein; RRT, renal replacement therapy; BP, blood pressure; PTH, parathyroid hormone; MACE, major adverse cardiovascular events.